In yesterday’s Wall Street session, Pfizer Inc (NYSE:PFE) shares traded at $26.42, down -1.20% from the previous session.
PFE stock price is now 0.56% away from the 50-day moving average and -5.09% away from the 200-day moving average. The market capitalization of the company currently stands at $149.72B.
On November 15, 2024, Wolfe Research recently initiated its ‘Underperform’ rating on the stock quoting a target price of $25, while ‘Citigroup’ rates the stock as ‘Neutral’
In other news, BLAYLOCK RONALD E, Director bought 19,457 shares of the company’s stock on Feb 13 ’25. The stock was bought for $499,072 at an average price of $25.65. Upon completion of the transaction, the Director now directly owns 27,707 shares in the company, valued at $0.73 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 30 ’24, Director Gottlieb Scott bought 1,000 shares of the business’s stock. A total of $28,240 was incurred on buying the stock at an average price of $28.24. This leaves the insider owning 10,000 shares of the company worth $0.26 million. A total of 0.07% of the company’s stock is owned by insiders.
During the past 12 months, Pfizer Inc has had a low of $24.48 and a high of $31.54. As of last week, the company has a debt-to-equity ratio of 0.73, a current ratio of 1.00, and a quick ratio of 0.73.
The net profit margin was 12.62% and return on equity was 4.52% for PFE. The company reported revenue of $17.76 billion for the quarter, compared to $13.51 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 31.46 percent.
